Features | Partner Sites | Information | LinkXpress
Sign In
TERARECON, INC.
AMPRONIX
SCHILLER AG

Ultrasound Screening Effective for Second Trimester Markers for Down’s Syndrome

By Medimaging International staff writers
Posted on 11 Feb 2013
A new analysis has found that some second trimester markers for Down’s syndrome that are detected by ultrasound are more important than other markers for the disease. Insights from this research should help adjust pregnant women’s risks for having a child with the disorder.

Down’s syndrome screening is offered to all pregnant women, starting with a background risk based on their age. Specific characteristics identified during a second trimester ultrasound scanning are possible markers for Down’s syndrome, and they include increased thickness of the back of the neck, dilated brain ventricles, absent or small nose bone, an abnormal artery to the upper extremities, bright spots in the heart, “bright” bowels, mild kidney swelling, and shortening of an arm bone or thigh bone.

To determine how these markers affect risk, Kypros Nicolaides, MD, from the Harris Birthright Research Center for Fetal Medicine at King’s College London (UK), and his colleagues analyzed all published data that reported findings on second trimester markers for Down’s syndrome between 1995 and 2012. The findings were published early online January 24, 2013, in the journal Ultrasound in Obstetrics & Gynecology.

The researchers identified 48 studies, and they discovered that most single markers have only a small effect on modifying the risks for Down’s syndrome. This finding could have important clinical implications because currently in the United States, when a marker such as a thighbone or short arm is identified, women are told that they are at high risk of having a child with Down’s syndrome. However, Dr. Nicolaides and his coworkers discovered that a few markers do carry increased risks. Increased thickness of the back of the neck, dilated brain ventricles, and an abnormal artery to the upper extremities increase the risk by three- to four-fold, and an absent or small nose bone increases the risk by six- to seven-fold.

“The detection of any one of the findings during the scan should prompt the sonographer to look for all other markers or abnormalities,” said Prof. Nicolaides. He added that the study also revealed that if a detailed second trimester ultrasound scan shows the absence of all major markers, the risk of having an infant affected by Down’s syndrome is decreased by more than seven-fold.

The study findings implied that the comparative significance of ultrasound markers is very different from what has been earlier believed. Prof. Nicolaides noted that these findings will be incorporated in obstetric ultrasound scan software that adjusts women’s risks for having a child with Down’s syndrome.

Related Links:
Harris Birthright Research Centre for Fetal Medicine at King’s College London



RTI ELECTRONICS AB
RADCAL
SuperSonic Imagine

Channels

MRI

view channel
Image: The quantitative character of the novel 3D technique on MR scans from a patient with primary liver cancer is demonstrated. Images A and B show the scan of the patient before being treated with chemoembolization. The new 3D technique helped quantify the volume and distribution of viable tumor tissue (shown in red and yellow colors). Images C and D demonstrate MR scans acquired after the treatment. The new 3D method helped the radiologists to quantify the vast central destruction of the tumor after the treatment (the dead tumor is represented by the blue color) (Photo courtesy of Johns Hopkins Medicine).

3D MRI Offers Improved Prediction of Survival After Chemotherapy for Liver Tumors

Researchers are using specialized three-dimensional (3D) magnetic resonance imaging (MRI) scanning technology to accurately measure living and dying liver tumor tissue in order to quickly show whether... Read more

Nuclear medicine

view channel
Image: Sagittal section of brain PET image at four hours after 64CuCl2 injection with disulfiram or D-penicillamine in MD model mice (Photo courtesy of the RIKEN Center for Life Science Technologies).

PET Imaging Used to Assess Effectiveness of Menkes Disease Treatments

Japanese scientists are using positron emission tomography (PET) imaging to visualize the distribution of copper in the body using lab mice. Copper distribution is deregulated in a genetic disorder called... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Software Designed for the Assessment of Orthopedic Implant Fixation and Bone Segment Motion

Model-based roentgen stereophotogrammetric analysis (MBRSA) software has been developed for evaluation of orthopedic implant fixation and bone segment motion. The software is the first to measure the in vivo three-dimensional (3D) position and/or relative motion of metal implants, markers beads, and/or bone segments in... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.